The Light Chain Allosterically Enhances the Protease Activity of Murine Urokinase-Type Plasminogen Activator

被引:0
|
作者
Torres-Paris, Constanza [1 ]
Song, Harriet J. [1 ]
Engelberger, Felipe [2 ,3 ,4 ,5 ]
Ramirez-Sarmiento, Cesar A. [2 ,3 ,4 ,5 ]
Komives, Elizabeth A. [1 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, Mail Code 0309, La Jolla, CA 92161 USA
[2] Pontificia Univ Catolica Chile, Inst Biol & Med Engn, Sch Engn, Santiago 7820436, Chile
[3] Pontificia Univ Catolica Chile, Inst Biol & Med Engn, Sch Med, Santiago 7820436, Chile
[4] Pontificia Univ Catolica Chile, Inst Biol & Med Engn, Sch Biol Sci, Santiago 7820436, Chile
[5] Millennium Inst Integrat Biol iBio, ANID Millennium Sci Initiat Program, Santiago 8331150, Chile
关键词
CATALYTIC DOMAIN; A-CHAIN; CRYSTAL-STRUCTURE; SERINE-PROTEASE; EXCHANGE; DYNAMICS; BINDING; SUBSTITUTION; MUTATIONS; MECHANISM;
D O I
10.1021/acs.biochem.4c00071
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The active form of the murine urokinase-type plasminogen activator (muPA) is formed by a 27-residue disordered light chain connecting the amino-terminal fragment (ATF) with the serine protease domain. The two chains are tethered by a disulfide bond between C1(CT) in the disordered light chain and C122(CT) in the protease domain. Previous work showed that the presence of the disordered light chain affected the inhibition of the protease domain by antibodies. Here we show that the disordered light chain induced a 3.7-fold increase in k cat of the protease domain of muPA. In addition, hydrogen-deuterium exchange mass spectrometry (HDX-MS) and accelerated molecular dynamics (AMD) were performed to identify the interactions between the disordered light chain and the protease domain. HDX-MS revealed that the light chain is contacting the 110s, the turn between the beta 10- and beta 11-strand, and the beta 7-strand. A reduction in deuterium uptake was also observed in the activation loop, the 140s loop and the 220s loop, which forms the S1-specificty pocket where the substrate binds. These loops are further away from where the light chain seems to be interacting with the protease domain. Our results suggest that the light chain most likely increases the activity of muPA by allosterically favoring conformations in which the specificity pocket is formed. We propose a model by which the allostery would be transmitted through the beta-strands of the beta-barrels to the loops on the other side of the protease domain.
引用
收藏
页码:1434 / 1444
页数:11
相关论文
共 50 条
  • [1] Inhibitors of the protease domain of urokinase-type plasminogen activator
    Rockway, TW
    Nienaber, V
    Giranda, VL
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (28) : 2541 - 2558
  • [2] THE MURINE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE
    DEGEN, SJF
    HECKEL, JL
    REICH, E
    DEGEN, JL
    [J]. BIOCHEMISTRY, 1987, 26 (25) : 8270 - 8279
  • [3] Characterization of the murine plasminogen/urokinase-type plasminogen-activator system
    Lijnen, HR
    VanHoff, B
    Collen, D
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 241 (03): : 840 - 848
  • [4] Urokinase-type plasminogen activator
    Crippa, Massimo P.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (04): : 690 - 694
  • [5] Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator
    Jo, MJ
    Thomas, KS
    Marozkina, N
    Amin, TJ
    Silva, CM
    Parsons, SJ
    Gonias, SL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (17) : 17449 - 17457
  • [6] DIFFERENTIAL DETECTION OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND 2 CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN AND MONKEY PLASMA
    MOLINARI, A
    GIORGETTI, C
    BONOMINI, L
    GERNA, M
    LANSEN, J
    GUREWICH, V
    [J]. FIBRINOLYSIS, 1992, 6 (01) : 17 - 26
  • [7] THE MURINE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR GENE
    SUH, TT
    NERLOV, C
    DANO, K
    DEGEN, JL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (42) : 25992 - 25998
  • [8] A Disordered Linker Regulates the Dynamics and Activity of the Protease Domain of the Urokinase-Type Plasminogen Activator
    Paris, Constanza Torres
    Komives, Elizabeth A.
    [J]. CIRCULATION, 2021, 144
  • [9] The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
    Carriero, Maria Vincenza
    Stoppelli, Maria Patrizia
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (19) : 1944 - 1961
  • [10] Hemostatic changes after thrombolytic therapy with saruplase (unglycosylated single-chain urokinase-type plasminogen activator) and urokinase (two-chain urokinase-type plasminogen activator)
    Michels, HR
    Hoffmann, JJML
    Windeler, J
    Hopkins, GR
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (08) : 766 - 771